Ambulatory, Office-based, and Geriatric Urology| Volume 120, P23-29, October 2018

Download started.


Chronic Prostatitis and/or Chronic Pelvic Pain as a Psychoneuromuscular Disorder—A Meta-analysis



      To evaluate effectiveness of physical therapy, biofeedback, and/or cognitive behavioral therapy for chronic prostatitis/chronic pelvic pain syndrome (CP and/or CPPS). This symptom complex has resisted resolution from conventional urologic treatment of the prostate, which includes antibiotics, alpha-blockers, and analgesics. Beginning in 1995, a new paradigm was introduced viewing CP and/or CPPS as a psychoneuromuscular disorder driven by protective pelvic floor guarding and psychosocial stress.


      A literature search (PubMed, Google Scholar, and the Cochran Library) was conducted from inception through December 2017 using key words related to CP and/or CPPS (eg, prostatitis and pelvic pain) with physical therapy (eg, myofascial trigger point release) and/or biofeedback or cognitive behavioral treatment. Studies were required to include pre- and post-treatment with the National Institutes of Health Chronic Prostatitis Symptom Index (CPSI) scores.


      Eight studies inclusive of 280 patients met primary inclusion criteria. Study sample sizes ranged from 8 to 116 men (mean = 35); treatment duration ranged from 8 to 26 weeks (mean = 14). Pretreatment mean CPSI scores ranged from 21.7 to 33.5. The nonstandardized weighted mean reduction of CPSI score from baseline was 8.8 points; 95% confidence interval (7.5, 11.1); P <.001. The I2 statistic = 18.5% indicating little heterogeneity between studies. A sensitivity analysis including an additional multimodal intervention study of with 100 patients produced similar findings.


      Conventional medical treatment often fails to resolve CP and/or CPPS. A 6-point reduction in CPSI score is considered a clinically meaningful improvement of symptoms. This meta-analysis shows that treating CP and/or CPPS as a psychoneuromuscular disorder can significantly exceed this clinical threshold.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Krieger JN
        • Nyberg Jr, L
        • Nickel JC
        NIH consensus definition and classification of prostatitis.
        JAMA. 1999; 282 (PMID: 10422990): 236-237
        • Krieger JN
        • Lee SW
        • Jeon J
        • et al.
        Epidemiology of prostatitis.
        Int J Antimicrob Agents. 2008; 31 (PMID: 18164907): 85-90
        • Pontari MA
        • Lebed B
        Prostate pain syndrome etiology, epidemiology, and research.
        Urogenital Pain Clin Prac. 2007; 9: 211
        • Schaeffer AJ
        • Knauss JS
        • Landis JR
        • et al.
        Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study.
        J Urol. 2002; 168 (PMID: 12187220): 1048-1053
        • Schaeffer AJ
        Epidemiology and evaluation of chronic pelvic pain syndrome in men.
        Int J Antimicrob Agents. 2008; 31: 108-111
        • Anderson RU
        • Harvey RH
        • Wise D
        • et al.
        Chronic pelvic pain syndrome: reduction of medication use after pelvic floor physical therapy with an internal myofascial trigger point wand.
        Appl Psychophysiol Biofeedback. 2015; 40: 45-52
        • Kaplan SA
        • Santarosa RP
        • D'Alisera PM
        • et al.
        Pseudodyssynergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option.
        J Urol. 1997; 157: 2234-2237
        • Wenninger K
        • Heiman JR
        • Rothman I
        • et al.
        Sickness impact of chronic nonbacterial prostatitis and its correlates.
        J Urol. 1996; 155 (PMID: 8583619): 965-988
        • Anothaisintawee T
        • Attia J
        • Nickel JC
        • et al.
        Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis.
        JAMA. 2011; 305: 78-86
        • Nickel JC
        • Shoskes DA
        • Wagenlehner FM
        Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): the studies, the evidence, and the impact.
        World J Urol. 2013; 31: 747-753
        • Magistro G
        • Wagenlehner FM
        • Grabe M
        • et al.
        Contemporary management of chronic prostatitis/chronic pelvic pain syndrome.
        Eur Urol. 2016; 69: 286-297
        • Bowen DK
        • Dielubanza E
        • Schaeffer AJ
        Chronic bacterial prostatitis and chronic pelvic pain syndrome.
        BMJ Clin Evid. 2015; 8 (PMCID: PMC4551133): 1802
        • Anderson RU
        • Nathanson BH
        Pain: drug therapies for CP/CPPS: help or hype?.
        Nat Rev Urol. 2011; 8 (PMID: 21562480): 236-237
        • Anderson RU
        • Wise D
        • Sawyer T
        • Chan C
        Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men.
        J Urol. 2005; 174 (PMID: 15947608): 155-160
        • FitzGerald MP
        • Kotarinos R
        Rehabilitation of the short pelvic floor. I: background and patient evaluation.
        Int Urogyn J. 2003; 14 (PMID: 14530840): 261-268
        • Potts JM
        Male pelvic pain: beyond urology and chronic prostatitis.
        Cur Rheum Rev. 2016; 12 (PMID: 26717951): 27-39
        • Litwin MS
        • McNaughton-Collins M
        • Fowler FJ
        • et al.
        The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure.
        J Urol. 1999; 162 (PMID: 10411041): 369-375
        • Litwin MS
        A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index.
        Urology. 2002; 60 (PMID: 12521581): 14-18
        • Hirji KF
        • Fagerland MW
        Calculating unreported confidence intervals for paired data.
        BMC Med Res Method. 2011; 11: 66
        • Wan X
        • Wang W
        • Liu J
        • Tong T
        Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range.
        BMC Med Res Method. 2014; 14: 135
        • Polackwich AS
        • Li J
        • Shoskes DA
        Patients with pelvic floor muscle spasm have a superior response to pelvic floor physical therapy at specialized centers.
        J Urol. 2015; 194: 1002-1006
        • Shoskes DA
        • Nickel JC
        • Kattan MW
        Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
        Urology. 2010; 75: 1249-1253
        • Tripp DA
        • Nickel JC
        • Katz L
        A feasibility trial of a cognitive-behavioural symptom management program for chronic pelvic pain for men with refractory chronic prostatitis/chronic pelvic pain syndrome.
        Can Urol Assoc J. 2011; 5: 328-332
        • He W
        • Chen M
        • Zu X
        • et al.
        Chronic prostatitis presenting with dysfunctional voiding and effects of pelvic floor biofeedback treatment.
        BJU Int. 2010; 105: 975-977
        • Masterson TA
        • Masterson JM
        • Azzinaro J
        • et al.
        Comprehensive pelvic floor physical therapy program for men with idiopathic chronic pelvic pain syndrome: a prospective study.
        Trans Androl Urol. 2017; 6: 910-915
        • FitzGerald MP
        • Anderson RU
        • Potts J
        • et al.
        Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes.
        J Urol. 2009; 182: 570-580
        • Cornel EB
        • van Haarst EP
        • Schaarsberg RW
        • Geels J
        The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III.
        Eur Urol. 2005; 47 (PMID: 15826751): 607-611
        • Anderson RU
        • Wise D
        • Sawyer T
        • et al.
        6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training.
        J Urol. 2011; 185: 1294-1299
        • Nadler RB
        Bladder training biofeedback and pelvic floor myalgia.
        Urology. 2002; 60 (PMID: 12521595): 42-43
        • Propert KJ
        • McNaughton-Collins M
        • Leiby BE
        • et al.
        A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort study.
        J Urol. 2006; 175 (PMID: 16407009): 619-623